Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Veterinary API Market, by Route of Administration
1.4.2 Europe Veterinary API Market, by API Type
1.4.3 Europe Veterinary API Market, by Synthesis Type
1.4.4 Europe Veterinary API Market, by Animal Type
1.4.5 Europe Veterinary API Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Force Analysis
Chapter 4. Strategies Deployed in Veterinary API Market
Chapter 5. Europe Veterinary API Market by Route of Administration
5.1 Europe Oral Market by Country
5.2 Europe Injectable Market by Country
5.3 Europe Topical Market by Country
5.4 Europe Others Market by Country
Chapter 6. Europe Veterinary API Market by API Type
6.1 Europe Parasiticides Market by Country
6.2 Europe Anti-inflammatory Market by Country
6.3 Europe Antimicrobials Market by Country
6.4 Europe Vaccines Market by Country
6.5 Europe Hormones Market by Country
6.6 Europe Others Market by Country
Chapter 7. Europe Veterinary API Market by Synthesis Type
7.1 Europe Chemical based API Market by Country
7.2 Europe Biological API Market by Country
7.3 Europe Highly potent API Market by Country
Chapter 8. Europe Veterinary API Market by Animal Type
8.1 Europe Livestock Animals Market by Country
8.2 Europe Companion Animals Market by Country
Chapter 9. Europe Veterinary API Market by Country
9.1 Germany Veterinary API Market
9.1.1 Germany Veterinary API Market by Route of Administration
9.1.2 Germany Veterinary API Market by API Type
9.1.3 Germany Veterinary API Market by Synthesis Type
9.1.4 Germany Veterinary API Market by Animal Type
9.2 UK Veterinary API Market
9.2.1 UK Veterinary API Market by Route of Administration
9.2.2 UK Veterinary API Market by API Type
9.2.3 UK Veterinary API Market by Synthesis Type
9.2.4 UK Veterinary API Market by Animal Type
9.3 France Veterinary API Market
9.3.1 France Veterinary API Market by Route of Administration
9.3.2 France Veterinary API Market by API Type
9.3.3 France Veterinary API Market by Synthesis Type
9.3.4 France Veterinary API Market by Animal Type
9.4 Russia Veterinary API Market
9.4.1 Russia Veterinary API Market by Route of Administration
9.4.2 Russia Veterinary API Market by API Type
9.4.3 Russia Veterinary API Market by Synthesis Type
9.4.4 Russia Veterinary API Market by Animal Type
9.5 Spain Veterinary API Market
9.5.1 Spain Veterinary API Market by Route of Administration
9.5.2 Spain Veterinary API Market by API Type
9.5.3 Spain Veterinary API Market by Synthesis Type
9.5.4 Spain Veterinary API Market by Animal Type
9.6 Italy Veterinary API Market
9.6.1 Italy Veterinary API Market by Route of Administration
9.6.2 Italy Veterinary API Market by API Type
9.6.3 Italy Veterinary API Market by Synthesis Type
9.6.4 Italy Veterinary API Market by Animal Type
9.7 Rest of Europe Veterinary API Market
9.7.1 Rest of Europe Veterinary API Market by Route of Administration
9.7.2 Rest of Europe Veterinary API Market by API Type
9.7.3 Rest of Europe Veterinary API Market by Synthesis Type
9.7.4 Rest of Europe Veterinary API Market by Animal Type
Chapter 10. Company Profiles
10.1 Boehringer Ingelheim International Gmbh
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Regional & Segmental Analysis
10.1.4 Research & Development Expenses
10.1.5 Recent strategies and developments:
10.1.5.1 Product Launches and Product Expansions:
10.1.5.2 Partnerships, Collaborations and Agreements:
10.1.6 SWOT Analysis
10.2 Zoetis, Inc.
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Regional Analysis
10.2.4 Research & Development Expense
10.2.5 Recent strategies and developments:
10.2.5.1 Product Launches and Product Expansions:
10.2.5.2 Approvals and Trials:
10.2.5.3 Acquisition and Mergers:
10.2.6 SWOT Analysis
10.3 Elanco Animal Health, Inc.
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Regional Analysis
10.3.4 Research & Development Expense
10.3.5 Recent strategies and developments:
10.3.5.1 Acquisition and Mergers:
10.3.6 SWOT Analysis
10.4 Merck & Co., Inc.
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Segmental and Regional Analysis
10.4.4 Research & Development Expenses
10.4.5 Recent strategies and developments:
10.4.5.1 Geographical Expansions:
10.4.6 SWOT Analysis
10.5 Virbac
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Regional Analysis
10.5.4 Recent strategies and developments:
10.5.4.1 Product Launches and Product Expansions:
10.5.5 SWOT Analysis
10.6 Vetoquinol SA (Soparfin SCA)
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 SWOT Analysis
10.7 Sequent Scientific Limited
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Regional Analysis
10.7.4 SWOT Analysis
10.8 Phibro Animal Health Corporation
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Segmental and Regional Analysis
10.8.4 Research & Development Expenses
10.8.5 SWOT Analysis
10.9 Febbrica Italina Sintetici S.P.A. (Nine Trees Group S.p.A)
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Regional Analysis
10.10. Excel Industries Limited
10.10.1 Company Overview
10.10.2 Financial Analysis
10.10.3 Segmental Analysis
10.10.4 SWOT Analysis
Unique Offerings 